Conferences & Events News Channel

SMi's 9th Annual Conference Pre-Filled Syringes East Coast

25 - 26 April 2022, Boston, MA, USA.
The global pre-filled syringes market was valued at $1139.6 million in 2020 and with the rapid growth of the industry, is expected to grow at a CAGR of 8.95% up to 2027. With that in mind, the 9th annual Pre-Filled Syringes East Coast conference will bring together leading industry experts representing big pharma and device developers to discuss the key drivers accelerating the expansion of the industry.

SMi Presents the 16th Annual Conference: Parallel Trade 2022

21 - 22 March 2022, Virtual Conference.
SMi presents its 16th annual Parallel Trade conference on the 21st and the 22nd March 2022. As the only parallel trade conference in Europe, this event provides the perfect platform for industry experts from both sides of the coin to come together and share perspectives on the practice of parallel trade.

SMi Group's 13th Annual Conference: RNA Therapeutics 2022

9 - 10 February 2022, Virtual Conference.
The RNA therapeutics industry has grown at an exponential rate in recent years, with an increased spotlight following the industry's leading role in developing vaccines against COVID-19 in response to the global pandemic. This year's conference will reflect on how the industry has adapted and played a pivotal role in global health over the past year and will discuss the takeaways for future mRNA therapeutic development.

SMi's 5th Annual 3D Cell Culture Conference

9 - 10 February 2022, Virtual Conference: Online Access Only.
3D Cell Culture is gaining momentum in the pharmaceutical industry on account of the advantages such models pose for in drug discovery, from improved clinical translation and predictivity, to patient safety and sustainability.

New vaccine ingredient shows promise

Scientists at La Jolla Institute for Immunology (LJI) and Massachusetts Institute of Technology (MIT), have found a possible way to improve the effectiveness of COVID-19 vaccines - and any vaccine.

Their new research, published in Science Immunology, shows that a "combination" adjuvant called a saponin/TLR agonist may boost the protective power of vaccines.

Modernise your Medical Affairs Insight Management with ViiV Healthcare, Eisai, ASC Therapeutics and Within3

9 December, 2021. 10AM EST, 3PM GMT, 4PM CET. Virtual Event.
Medical affairs teams are challenged by rising costs and accelerated timelines - and hampered by inefficiency throughout the insight gathering process. These breakdowns occur before a single insight is collected: by engaging with the wrong KOLs, medical affairs won't access the right strategic insights while wasting time and effort.

Novartis, Bayer and Boehringer Ingelheim to showcase their commitment to a reimagined pharma industry

11 - 22 October, 2021, Virtual
Board level executives from Novartis, Bayer and Boehringer Ingelheim, amongst many more, will showcase their long-term visions for healthcare as a response to the COVID-19 pandemic, by joining the speaker faculty at Reuters Events Pharma Europe 2021.

Conferences & Events News

SMi's 9th Annual Conference Pre-Filled Syringes East Coast

SMi Presents the 16th Annual Conference: Parallel Trade 2022

SMi Group's 13th Annual Conference: RNA Therapeutics 2022

SMi's 5th Annual 3D Cell Culture Conference

New vaccine ingredient shows promise

Modernise your Medical Affairs Insight Management with ViiV Healthcare, Eisai, ASC Therapeutics and Within3

Novartis, Bayer and Boehringer Ingelheim to showcase their commitment to a reimagined pharma industry

More Pharma News ...

Business & Industry

Research & Development

Conferences & Events

Regulatory Affairs